Oligonucleotide Synthesis, Modification, and Purification Services Market- by Product
Oligonucleotide Synthesis, Modification, and Purification Services Market- Application
Oligonucleotide Synthesis, Modification, and Purification Services Market- Type
Oligonucleotide Synthesis, Modification, and Purification Services Market- End-users
Global Oligonucleotide Synthesis, Modification, and Purification Services Market, by Region,
North America Oligonucleotide Synthesis, Modification, and Purification Services Market, by Country,
Europe Oligonucleotide Synthesis, Modification, and Purification Services Market, by Country,
Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market, by Country,
Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market, by Country,
Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market, by Country,
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oligonucleotide Synthesis, Modification, and Purification Services Market Snapshot
Chapter 4. Global Oligonucleotide Synthesis, Modification, and Purification Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Oligonucleotide Synthesis, Modification, and Purification Services Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on OLIGONUCLEOTIDE SYNTHESIS, MODIFICATION, AND PURIFICATION SERVICES MARKET Industry Trends
Chapter 5. Oligonucleotide Synthesis, Modification, and Purification Services Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product:
5.2.1. Primers
5.2.2. Probes
5.2.3. DNA Oligos
5.2.3.1. Molecular Beacons
5.2.3.2. Randomer Oligos
5.2.3.3. Unlocked nucleobase analog (UNA) and twisted intercalating nucleic acid (TINA) Oligos
5.2.3.4. Others (Light-activated Oligos, Chimeric Oligos and Trimers Mixes)
5.2.4. RNA Oligos
5.2.4.1. Single Guide RNA (sgRNA)
5.2.4.2. Small Interfering RNA (siRNA)
5.2.4.3. MicroRNA (miRNA)
5.2.4.4. Antisense Oligo (ASO)
5.2.4.5. Sequencing Primers
5.2.4.6. Aptamers
5.2.4.7. Others (Long RNA, etc.)
5.2.5. Others
Chapter 6. Oligonucleotide Synthesis, Modification, and Purification Services Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Therapeutic Applications
6.2.1.1. Neurological Disorders
6.2.1.2. Rare Diseases
6.2.1.3. Other Diseases
6.2.2. Research Applications
6.2.2.1. PCR
6.2.2.2. Sequencing
6.2.2.3. Other Research Applications
6.2.3. Diagnostic Applications
Chapter 7. Oligonucleotide Synthesis, Modification, and Purification Services Market Segmentation 3: By Type, Estimates & Trend Analysis
7.1. Market Share by Type, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type:
7.2.1. Customized Oligos
7.2.2. Predesigned Oligos
7.2.3. Reagents & Consumables
7.2.4. Equipment
Chapter 8. Oligonucleotide Synthesis, Modification, and Purification Services Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share by End User, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
8.2.1. Hospitals
8.2.2. Pharmaceutical & Biotechnology Companies
8.2.3. Diagnostic Laboratories
8.2.4. CROs and CMOs
8.2.5. Academic Research Institutes
Chapter 9. Oligonucleotide Synthesis, Modification, and Purification Services Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Oligonucleotide Synthesis, Modification, and Purification Services Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.2.3. North America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. North America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.2.5. North America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3. Europe
9.3.1. Europe Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.3.3. Europe Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Europe Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.3.5. Europe Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.4.3. Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
9.4.5. Asia Pacific Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5. Latin America
9.5.1. Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.5.3. Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.5.5. Latin America Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.6.3. Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.4. Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.6.5. Middle East & Africa Oligonucleotide Synthesis, Modification, and Purification Services Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Agilent Technologies
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service Type
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Ajinomoto Bio-Pharma Services
10.2.3. CordenPharma
10.2.4. Integrated DNA Technologies
10.2.5. Kaneka Eurogentec
10.2.6. LGC Biosearch Technologies
10.2.7. Microsynth
10.2.8. Merck KGaA
10.2.9. Nitto Avecia
10.2.10. Thermo Fisher Scientific
10.2.11. TriLink BioTechnologies
10.2.12. Creative Biolabs
10.2.13. Ella Biotech
10.2.14. Eurofins Scientific
10.2.15. Ribo Biotechnology
10.2.16. WuXi AppTec
10.2.17. GE Healthcare
10.2.18. Bio-synthesis Inc.
10.2.19. Almac Group
10.2.20. Sumitomo Chemical
10.2.21. BioSpring
10.2.22. ChemGenes
10.2.23. BianoScience GmbH
10.2.24. ATDBio Ltd
10.2.25. Burkert UK Limited
10.2.26. IBA Lifesciences GmbH
10.2.27. Other Market Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.